Case #3: A Case of Bioprosthetic Valve Fracture To Facilitate TAVR ViV

Case #2: A Case of TAVR in TAVR

Case #1: A Case of TAVR ViV Requiring an Advanced Approach

Introduction: What Do We Hope to Learn From These Cases?

Should We Anticoagulate “All” Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

‘To Split or Not to Split’: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

‘To Crack or Not to Crack’: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures